Veterinary Molecular Diagnostic Market by Product, Technology, Animal Type, Disease Indication, End User - Global Forecast 2025-2030- Product Image

Sale

Veterinary Molecular Diagnostic Market by Product, Technology, Animal Type, Disease Indication, End User - Global Forecast 2025-2030

Report
198 Pages
October 2024
Region: Global
360iResearch™
ID: 4986086

UP TO €681EUR$697USD£568GBP OFF until Dec 31^st 2024

The Veterinary Molecular Diagnostic Market grew from USD 579.74 million in 2023 to USD 632.40 million in 2024. It is expected to continue growing at a CAGR of 9.17%, reaching USD 1.07 billion by 2030.

The veterinary molecular diagnostic market is fundamentally concerned with the use of advanced molecular biology techniques for diagnosing veterinary diseases at the genomic level. This scope covers tools like PCR (Polymerase Chain Reaction), microarrays, biosensors, and next-generation sequencing, tailored to identify pathogens and genetic anomalies in animals. The necessity of these diagnostics arises from the increasing demand for effective animal healthcare, fueled by the rising incidence of zoonotic diseases and the need for precise, rapid, and cost-efficient diagnostic solutions. Applications span across companion and livestock animals, aiding in disease detection, vaccination, breeding programs, pathogen surveillance, and food safety. Growing livestock population, heightened awareness about pet healthcare, and robust advancements in biotechnology are key factors propelling market growth. Additionally, the regulatory frameworks aimed at animal health protections and a rise in R&D investments offer potent opportunities, especially in personalized medicine and preventive healthcare approaches for animals.

Opportunities exist in expanding the use of point-of-care diagnostics and portable testing devices, which can transform veterinary care by making diagnostics accessible even in remote areas. Biotechnology firms can capitalize on gaps in current market offerings by developing multi-pathogen diagnostic tests and enhancing test accuracy through AI-driven analytics, thus improving the predictive capabilities of diagnostic tools. However, high costs, lack of skilled personnel, and inconsistent regulatory environments pose significant limitations. The market also faces challenges from economic fluctuations impacting funding and investment priorities. Innovation should focus on reducing costs and optimizing supply chain efficiencies along with fostering collaborative research to navigate these growth barriers. Hybrid technologies integrating AI and big data analytics with molecular diagnostics present a burgeoning frontier for research and development. Overall, the market is dynamic, evidencing a strong demand trajectory but necessitating strategic navigation through its multifaceted challenges.

Understanding Market Dynamics in the Veterinary Molecular Diagnostic Market

The Veterinary Molecular Diagnostic Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Increasing number of companion animal and livestock ownership
- Improving veterinary care facilities in economies
- Rising incidence of chronic diseases in animals
Market Restraints
- High cost associated with sophisticated molecular diagnostics instruments and assays
Market Opportunities
- Advances in veterinary molecular diagnostic technology
- Growing availability of pet insurance
Market Challenges
- Lack of skilled professionals

Exploring Porter’s Five Forces for the Veterinary Molecular Diagnostic Market

Porter’s Five Forces framework further strengthens the insights of the Veterinary Molecular Diagnostic Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Veterinary Molecular Diagnostic Market

External macro-environmental factors deeply influence the performance of the Veterinary Molecular Diagnostic Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Veterinary Molecular Diagnostic Market

The Veterinary Molecular Diagnostic Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Veterinary Molecular Diagnostic Market

The Veterinary Molecular Diagnostic Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Veterinary Molecular Diagnostic Market

The Veterinary Molecular Diagnostic Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Molecular Diagnostic Market, highlighting leading vendors and their innovative profiles. These include Biochek BV, Biomedica Medizinprodukte GmbH, BioMérieux SA, Bioneer Corp, HealthGene Corporation, Heska Corporation, IDEXX Laboratories, Inc., Novacyt Group, Quality Vet Lab, Randox Laboratories, Ltd., Thermo Fisher Scientific, Inc., VCA, Inc., Veterinary Molecular Diagnostics Inc., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Molecular Diagnostic Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Instruments & Software
- Kits & Reagent
- Services
Technology
- DNA Sequencing
- Microarrays
- Polymerase Chain Reaction
Animal Type
- Companion Animal
  - Canine
  - Equine
  - Feline
- Livestock Animal
  - Bovine
  - Ovine or Caprine
  - Porcine
  - Poultry
Disease Indication
- Diarrhea Pathogens Detection
- Respiratory Pathogens Detection
- Vector Borne Diseases
End User
- Hospitals
- Reference Laboratories
- Veternary Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing number of companion animal and livestock ownership
5.1.1.2. Improving veterinary care facilities in economies
5.1.1.3. Rising incidence of chronic diseases in animals
5.1.2. Restraints
5.1.2.1. High cost associated with sophisticated molecular diagnostics instruments and assays
5.1.3. Opportunities
5.1.3.1. Advances in veterinary molecular diagnostic technology
5.1.3.2. Growing availability of pet insurance
5.1.4. Challenges
5.1.4.1. Lack of skilled professionals
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Veterinary Molecular Diagnostic Market, by Product

6.1. Introduction
6.2. Instruments & Software
6.3. Kits & Reagent
6.4. Services

7. Veterinary Molecular Diagnostic Market, by Technology

7.1. Introduction
7.2. DNA Sequencing
7.3. Microarrays
7.4. Polymerase Chain Reaction

8. Veterinary Molecular Diagnostic Market, by Animal Type

8.1. Introduction
8.2. Companion Animal
8.2.1. Canine
8.2.2. Equine
8.2.3. Feline
8.3. Livestock Animal
8.3.1. Bovine
8.3.2. Ovine or Caprine
8.3.3. Porcine
8.3.4. Poultry

9. Veterinary Molecular Diagnostic Market, by Disease Indication

9.1. Introduction
9.2. Diarrhea Pathogens Detection
9.3. Respiratory Pathogens Detection
9.4. Vector Borne Diseases

10. Veterinary Molecular Diagnostic Market, by End User

10.1. Introduction
10.2. Hospitals
10.3. Reference Laboratories
10.4. Veternary Clinics

11. Americas Veterinary Molecular Diagnostic Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Veterinary Molecular Diagnostic Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Veterinary Molecular Diagnostic Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. VETERINARY MOLECULAR DIAGNOSTIC MARKET RESEARCH PROCESS
FIGURE 2. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. VETERINARY MOLECULAR DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. VETERINARY MOLECULAR DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. VETERINARY MOLECULAR DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. VETERINARY MOLECULAR DIAGNOSTIC MARKET DYNAMICS
TABLE 7. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS & SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY KITS & REAGENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CANINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY EQUINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY FELINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY OVINE OR CAPRINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DIARRHEA PATHOGENS DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY RESPIRATORY PATHOGENS DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY VECTOR BORNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY VETERNARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 60. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 61. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 62. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 63. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 67. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 68. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 69. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 70. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 97. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 98. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 99. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 100. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 104. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 105. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 106. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 107. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 118. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 119. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 120. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 121. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 160. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 161. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 162. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 163. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 179. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 182. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 183. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 184. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 185. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 189. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 190. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 191. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 192. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 196. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 197. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 198. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 199. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 203. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 204. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 205. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 206. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 210. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 211. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 212. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 213. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 222. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 223. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 224. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 225. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 226. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 227. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 243. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 244. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 245. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 246. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 247. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 248. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 250. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 252. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 253. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 254. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 255. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 257. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 259. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 260. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 261. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 262. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 285. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 286. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 287. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 288. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 289. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 290. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 305. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 306. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 307. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 308. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
TABLE 309. TURKEY VETERINARY MOLEC

Companies Mentioned

The leading players in the Veterinary Molecular Diagnostic Market, which are profiled in this report, include:

Biochek BV
Biomedica Medizinprodukte GmbH
BioMérieux SA
Bioneer Corp
HealthGene Corporation
Heska Corporation
IDEXX Laboratories, Inc.
Novacyt Group
Quality Vet Lab
Randox Laboratories, Ltd.
Thermo Fisher Scientific, Inc.
VCA, Inc.
Veterinary Molecular Diagnostics Inc.
Virbac S.A.
Zoetis Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	198
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 632.4 Million
Forecasted Market Value ( USD ) by 2030	$ 1070 Million
Compound Annual Growth Rate	9.1%
Regions Covered	Global
No. of Companies Mentioned	15

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3464EUR$3,545USD£2,892GBP €3849EUR$3,939USD£3,213GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6128EUR$6,272USD£5,116GBP €6809EUR$6,969USD£5,684GBP

Understanding Market Dynamics in the Veterinary Molecular Diagnostic Market

Exploring Porter’s Five Forces for the Veterinary Molecular Diagnostic Market

Applying PESTLE Analysis to the Veterinary Molecular Diagnostic Market

Analyzing Market Share in the Veterinary Molecular Diagnostic Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Veterinary Molecular Diagnostic Market

Strategic Recommendations for Success in the Veterinary Molecular Diagnostic Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Veterinary Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

Veterinary Molecular Diagnostics Market Report by Product, Technology, Animal Type, Disease Type, End User, and Region 2024-2032

Veterinary Molecular Diagnostics - Global Strategic Business Report

Veterinary Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Veterinary Molecular Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

About the Veterinary Molecular Diagnostic Market